Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms Meeting Abstract


Authors: Grünwald, V.; Powles, T.; Kopyltsov, E.; Kozlov, V.; Gordoa, T. A.; Eto, M.; Hutson, T. E.; Motzer, R. J.; Winquist, E.; Maroto-Rey, P.; Keam, B.; Procopio, G.; Wong, S.; Melichar, B.; Rolland, F.; Oya, M.; Rodriguez-Lopez, K.; Saito, K.; Smith, A. D.; Porta, C.
Abstract Title: Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120602308
DOI: 10.1200/JCO.2021.39.15_suppl.4560
PROVIDER: wos
Notes: Meeting Abstract: 4560 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1248 Motzer